Vistin Pharma ASA: Mandatory notification of trade
23 March 2024 - 7:59AM
UK Regulatory
Vistin Pharma ASA: Mandatory notification of trade
Pactum Vekst AS has on March 22, 2024 sold 527 960 shares in
Vistin Pharma ASA at a price of NOK 22,10 per share. Espen W.
Marcussen, Chair of the board in Pactum Vekst AS, is a primary
insider and board member of Vistin Pharma ASA. Pactum Vekst AS is
fully owned by Pactum AS. The shares in Vistin Pharma are sold to
one of Pactum’s shareholders, as part of a share buy-back process
in Pactum.
After the transaction, Pactum Vekst AS owns 2 991 773
shares in Vistin Pharma ASA.
Please see attached document in accordance with the Market Abuse
Regulation article 19.
This notification has been submitted pursuant to the Securities
Trading Act section 5-12.
- Vistin Pharma_Notification of trade_Espen Marcussen_board
member
Vistin Pharma Asa (LSE:0RAM)
Historical Stock Chart
From Jan 2025 to Feb 2025
Vistin Pharma Asa (LSE:0RAM)
Historical Stock Chart
From Feb 2024 to Feb 2025